GAITHERSBURG, Md., Feb. 15, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the “Company” or “Cytomedix”), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announces that Martin P. Rosendale, President and Chief Executive Officer of Cytomedix, will deliver a corporate presentation as part of the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies On-Line Forum on Thursday, February 17, 2011 at 11:00 a.m. Eastern time.
